DiNuzzo Private Wealth
RVMD icon

DiNuzzo Private Wealth’s Revolution Medicines RVMD Stock Holding History

DiNuzzo Private Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.64K Hold
8
– – ﹤0.01% 724
2026
Q2 		$1.5K Sell
8
-7
-47% -$1.02K ﹤0.01% 775
2026
Q1 		$1.46K Hold
15
– – ﹤0.01% 756
2025
Q4 		$1.2K Buy
15
+9
+150% +$590 ﹤0.01% 825
2025
Q3 		$228 Buy
6
+3
+100% +$117 ﹤0.01% 1250
2025
Q2 		$111 Hold
3
– – ﹤0.01% 1295
2025
Q1 		$107 Hold
3
– – ﹤0.01% 1295
2024
Q4 		$132 Hold
3
– – ﹤0.01% 1318
2024
Q3 		$137 Hold
3
– – ﹤0.01% 1340
2024
Q2 		$117 Hold
3
– – ﹤0.01% 1330
2024
Q1 		$97 Hold
3
– – ﹤0.01% 1292
2023
Q4 		$87 Buy
+3
New +$72 ﹤0.01% 1334

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak Pty Ltd
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

DiNuzzo Private Wealth's RVMD Position: Q3 2026 in Review

DiNuzzo Private Wealth held its Revolution Medicines (RVMD) position steady in Q3 2026 at 8 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

DiNuzzo Private Wealth first reported a position in RVMD in Q4 2023 and has held it in 12 quarters since. 146 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • DiNuzzo Private Wealth held 8 shares of Revolution Medicines worth $1.64K as of Q3 2026.
  • DiNuzzo Private Wealth left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #724 holding.
  • DiNuzzo Private Wealth first reported a position in Revolution Medicines in Q4 2023 and has held it in 12 quarters since.
  • 146 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.